Bryce Point Capital, LLC 10x Genomics, Inc. Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 31,215 shares of TXG stock, worth $374,580. This represents 0.13% of its overall portfolio holdings.
Number of Shares
31,215Holding current value
$374,580% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
300Shares Held
97.3MCall Options Held
263KPut Options Held
85.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$143 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$131 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.48MShares$77.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$76.7 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$68.6 Million0.06% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.14B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...